CTNNA2 and non-small cell lung carcinoma: In our previous study, we detected that CARP was downregulated in non-small-cell lung cancer (NSCLC) tissue, and CAPR suppressed cell growth and motility in human lung carcinoma A549 cells by modulating several key G1/S-regulatory proteins [10].